Retinoic acid receptor and retinoid X receptor subtype expression for the differential diagnosis of thyroid neoplasms

European Journal of Endocrinology

Volumn 160, Issue 4, 2009, Pages 631-638

  Hoftijzer, Hendrieke C ^a   Liu, Ying Y ^a   Morreau, Hans ^a   van Wezel, Ton ^a   Pereira, Alberto M ^a   Corssmit, Eleonora P M ^a   Romijn, Johannes A ^a   Smit, Johannes W A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR; RETINOID X RECEPTOR BETA;

ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NODULAR GOITER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TISSUE MICROARRAY; BIOSYNTHESIS; CELL NUCLEUS; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; ROC CURVE; THYROID TUMOR; TUMOR RECURRENCE;

CELL NUCLEUS; CLUSTER ANALYSIS; CYTOPLASM; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; ROC CURVE; THYROID NEOPLASMS;

EID: 64549136274     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0812     Document Type: Article

References (25)

1. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS & de la Chapelle A. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. PNAS 2001 98 15044-15049.
2. Zhao J, Leonard C, Gemsenjager E, Heitz PU, Moch H & Odermatt B. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling. Oncology Reports 2008 19 329-337.
3. Zhao J, Leonard C, Brunner E, Gemsenjager E, Heitz PU & Odermatt B. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays. International Journal of Oncology 2006 29 1041-1051.
4. Lubitz CC & Fahey TJ III. Gene expression profiling of thyroid tumors - clinical applicability. Nature Clinical Practice. Endocrinology & Metabolism 2006 2 472-473.
5. Fryknas M, Wickenberg-Bolin U, Goransson H, Gustafsson MG, Foukakis T, Lee JJ, Landegren U, Hoog A, Larsson C, Grimelius L, Wallin G, Pettersson U & Isaksson A. Molecular markers for discrimination of benign and malignant follicular thyroid tumors. Tumour Biology 2006 27 211-220.
6. Eszlinger M, Wiench M, Jarzab B, Krohn K, Beck M, Lauter J, Gubala E, Fujarewicz K, Swierniak A & Paschke R. Meta- and reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene groups. Journal of Clinical Endocrinology and Metabolism 2006 91 1934-1942.
7. Fujarewicz K, Jarzab M, Eszlinger M, Krohn K, Paschke R, Oczko-Wojciechowska M, Wiench M, Kukulska A, Jarzab B & Swierniak A. A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping. Endocrine-Related Cancer 2007 14 809-826.
8. Rosen J, He M, Umbricht C, Alexander HR, Dackiw AP, Zeiger MA & Libutti SK. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Surgery 2005 138 1050-1056.
9. Stolf BS, Abreu CM, Mahler-Araujo MB, Dellamano M, Martins WK, de Carvalho MB, Curado MP, Diaz JP, Fabri A, Brentani H, Carvalho AF, Soares FA, Kowalski LP, Hirata R Jr & Reis LF. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas. Cancer Letters 2005 227 59-73.
10. Finley DJ, Lubitz CC, Wei C, Zhu B & Fahey TJ III. Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling. Thyroid 2005 15 562-568.
11. Wasenius VM, Hemmer S, Kettunen E, Knuutila S, Franssila K & Joensuu H. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNAand tissue microarray study. Clinical Cancer Research 2003 9 68-75.
12. Liu YY, Morreau H, Kievit J, Romijn JA, Carrasco N & Smit JW. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma. European Journal of Endocrinology 2008 158 375-384.
13. Smith MA, Parkinson DR, Cheson BD & Friedman MA. Retinoids in cancer therapy. Journal of Clinical Oncology 1992 10 839-864.
14. Rochaix P, Monteil-Onteniente S, Rochette-Egly C, Caratero C, Voigt JJ & Jozan S. Reduced expression of retinoic acid receptor beta protein (RAR beta) in human papillary thyroid carcinoma: immunohistochemical and western blot study. Histopathology 1998 33 337-343.
15. Schmutzler C, Brtko J, Winzer R, Jakobs TC, Meissner-Weigl J, Simon D, Goretzki PE & Kohrle J. Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues. International Journal of Cancer 1998 76 368-376.
16. Takiyama Y, Miyokawa N, Sugawara A, Kato S, Ito K, Sato K, Oikawa K, Kobayashi H, Kimura S & Tateno M. Decreased expression of retinoid X receptor isoforms in human thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism 2004 89 5851-5861.
17. Schmutzler C, Hoang-Vu C, Ruger B & Kohrle J. Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. European Journal of Endocrinology 2004 150 547-556.
18. Haugen BR, Larson LL, Pugazhenthi U, Hays WR, Klopper JP, Kramer CA & Sharma V. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids. Journal of Clinical Endocrinology and Metabolism 2004 89 272-280.
19. Elisei R, Vivaldi A, Agate L, Ciampi R, Molinaro E, Piampiani P, Romei C, Faviana P, Basolo F, Miccoli P, Capodanno A, Collecchi P, Pacini F & Pinchera A. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes. Journal of Clinical Endocrinology and Metabolism 2005 90 2403-2411.
20. Koh CS, Ku JL, Park SY, Kim KH, Choi JS, Kim IJ, Park JH, Oh SK, Chung JK, Lee JH, Kim WH, Kim CW, Cho BY & Park JG. Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene. Molecular and Cellular Endocrinology 2007 264 118-127.
21. Havekes B, Schroder Van Der Elst JP, van der PG, Goslings BM, Romijn JA & Smit JW. Beneficial effects of retinoic acid on extracellular matrix degradation and attachment behaviour in follicular thyroid carcinoma cell lines. Journal of Endocrinology 2000 167 229-238.
22. Simon D, Korber C, Krausch M, Segering J, Groth P, Gorges R, Grunwald F, Muller-Gartner HW, Schmutzler C, Kohrle J, Roher HD & Reiners C. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. European Journal of Nuclear Medicine and Molecular Imaging 2002 29 775-782.
23. Liu YY, Stokkel MP, Pereira AM, Corssmit EP, Morreau HA, Romijn JA & Smit JW. Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma. European Journal of Endocrinology 2006 154 525-531.
24. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G & Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Medicine 1998 4 844-847.
25. Toronen P. Selection of informative clusters from hierarchical cluster tree with gene classes. BMC Bioinformatics 2004 5 32.